Walter O. Whitley, OD

ATLANTA — A long-term study of Vevye for treating dry eye showed an improvement in Schirmer’s scores by 98% at week 46, according to Walter O. Whitley, OD, MBA, FAAO.

DENVER – Walt Whitley, OD, MBA, FAAO, presented an overview at this year’s Optometry’s Meeting on the current trends in presbyopia management, including available and upcoming technology and therapeutics.

Pooled analysis showed that KPI-121 0.25% from Kala Pharmaceuticals, a nanoparticle suspension of loteprednol etabonate with proprietary mucus-penetrating particle technology for dry eye treatment, was safe and well-tolerated.